Status:
NOT_YET_RECRUITING
Explore the Effect of Bitter Melon Peptides on Glycemic Control and Metabolic Indicators in Diabetic Patients
Lead Sponsor:
Changhua Christian Hospital
Collaborating Sponsors:
China Medical University, Taiwan
Conditions:
Diabetes
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn the potential of bitter melon peptides in stabilizing blood glucose in diabetic adults. It will also learn about the effects of bitter melon peptides on met...
Eligibility Criteria
Inclusion
- Participants were diagnosed with type 2 DM based on criteria recommended by the American Diabetes Association and required to have fasting plasma glucose of ≥126 mg/dl or an HbA1c of
- ≥ 6.5%, as measured on two separate occasions
Exclusion
- cancer, active liver disease, current pregnancy , acute illness and autoimmune thyroid disease.
Key Trial Info
Start Date :
May 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 26 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06970834
Start Date
May 27 2025
End Date
March 26 2026
Last Update
May 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.